Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II study.
Safran H, Charpentier KP, Kaubisch A, Mantripragada K, Dubel G, Perez K, Faricy-Anderson K, Miner T, Eng Y, Victor J, Plette A, Espat J, Bakalarski P, Wingate P, Berz D, Luppe D, Martel D, Rosati K, Aparo S.
Safran H, et al. Among authors: dubel g.
Am J Clin Oncol. 2015 Feb;38(1):1-4. doi: 10.1097/COC.0b013e3182868c66.
Am J Clin Oncol. 2015.
PMID: 23648434
Clinical Trial.